As of 2025-03-24, the EV/EBITDA ratio of Sangamo Therapeutics Inc (SGMO) is -0.86. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SGMO's latest enterprise value is 141.62 mil USD. SGMO's TTM EBITDA according to its financial statements is -164.15 mil USD. Dividing these 2 quantities gives us the above SGMO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 14.8x | 13.4x |
| Forward P/E multiples | 21.8x - 47.9x | 34.8x |
| Fair Price | (16.96) - (11.46) | (18.79) |
| Upside | -2057.4% - -1421.9% | -2268.4% |
| Date | EV/EBITDA |